FGFR3 and central nervous system cancer: Two cases presenting the co-occurrence of F3T3 and an FGFR3 K650T activating mutation have been reported [45]; the real incidence among F3T3 gliomas of concurrent activating FGFR3 mutations and their prognostic value remains to be defined.